Journal of Cancer Research and Immuno-Oncology is a fast-developing open access journal in the field of cancer research. It is a peer reviewed journal in the field of cancer research. Journal of Cancer Research and Immuno-Oncology covers a broad scope for the authors to make their valuable contributions in cancer biology, tumor, radiology, metastatis, cancer immunotherapy, oncology, radiation therapy etc

This Journal provides a unique forum dedicated to scientists to express their research articles, review articles, case reports and short communications on any array of latest cancer research and Immuno-Oncology. The Journal of Cancer Research and Immuno-Oncology is a Peer Reviewed Open Access. Journal supported by universally prominent Editorial Board members. Abstracts and full texts of all articles published by Journal of Cancer Research and Immuno-Oncology are freely accessible to everyone.

The journal is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking system. Review processing is performed by the editorial board members of Journal of Cancer Research and Immuno-Oncology or outside experts; approval of at least two independent reviewers followed by the editor is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

We are glad to announce that we are providing discounts for those who are submitting their manuscript on or before April 20,2020.

The journal offers author benefits which include

• The copyright of their own research outcomes, concepts and expert opinions
• Post-publication promotion of the published articles for enhanced visibility and citation probability
• Special discounts on processing charges based on the number, relevance and impact of the submissions
• Publication of the article within one week after the acceptance by the peer-reviewers (fast track review)

Interested can submit their manuscript through online portal

Submit manuscript at https://www.longdom.org/submissions/cancer-research-immuno-oncology.htmll or send as an e-mail attachment to the Editorial Office at cancerresearch@clinicalres.org

A manuscript number will be e-mailed to the corresponding author within 72 hours.

Longdom Publishing SL Policy Regarding the NIH Mandate

Longdom Publishing SL will support authors by posting the published version of articles by NIH grant-holders and European or UK-based biomedical or life sciences grant holders to PubMed Central immediately after publication

Editorial Policies and Process

Journal of Cancer Research and Immuno-Oncology follows a progressive editorial policy that encourages researchers to submit the original research, reviews and editorial observations as articles, well supported by tables and graphic representation.

Media contact:

Maegan Smith

Managing Editor

Journal of Cancer Research and Immuno-Oncology

Mail ID: cancerresearch@clinicalres.org       

WhatsApp no: + 1-504-608-2390